AGT and congestive heart failure: ASTRAAS-HF will test the effect of IONIS-AGT-LRx on AGT and N-terminal prohormone of B-type natriuretic peptide in 72 chronic heart failure participants with reduced ejection fraction (https://www.clinicaltrials.gov; Unique identifier: NCT04836182).